NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

NATCO Pharma had revenue of 7.35B INR in the quarter ending June 30, 2026, a decrease of -44.68%. This brings the company's total for the last twelve months to 34.85B, down -20.73% year-over-year. In the fiscal year ending March 31, 2026, NATCO Pharma had annual revenue of 40.82B, down -7.90%. That makes NATCO Pharma the 13,098th largest company in the world by revenue and 624th in India.

• Revenue (ttm): 34.85B
• Revenue Growth: -20.73%
• P/S Ratio: 4.04
• Revenue / Employee: 7.86M
• Employees: 4,433
• Market Cap: 140.49B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals 39.40B 96.6%
• Agro Chemicals 1.38B 3.4%

By Geography

Chart

• United States of America (USA) 23.81B 58.4%
• Rest of The World 10.06B 24.7%
• India 6.91B 16.9%

Fiscal year ended Mar 31, 2026 See the full NATCO Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.82B	-3.50B	-7.90%
Mar 31, 2025	44.32B	4.30B	10.74%
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error